KRAS and head and neck squamous cell carcinoma: Nevertheless, our study suggests that overexpression of wild‐type MB21D2 and Q311E mutation mediates pro‐oncogenic activities in HNSCC by positive enrichment of KRAS along with activation of PI3K‐AKT, and EMT factors.